{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:16:10Z","timestamp":1783354570769,"version":"3.54.6"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05263-5","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:33:27Z","timestamp":1783352007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cystatin C-creatinine eGFR discordance and all-cause mortality in adults with preserved creatinine-based kidney function: a dual-cohort study"],"prefix":"10.1007","author":[{"given":"Chengkai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"issue":"4S","key":"5263_CR1","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2024) KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 105(4S):S117\u2013S314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018","journal-title":"Kidney Int"},{"issue":"3","key":"5263_CR2","first-page":"1","volume":"2013","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO (2012) Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013(3):1\u2013150","journal-title":"Kidney Int Suppl"},{"key":"5263_CR3","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann Intern Med"},{"key":"5263_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","volume":"367","author":"LA Inker","year":"2012","unstructured":"Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T et al (2012) Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367:20\u201329. https:\/\/doi.org\/10.1056\/NEJMoa1114248","journal-title":"N Engl J Med"},{"key":"5263_CR5","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y et al (2021) New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med 385:1737\u20131749. https:\/\/doi.org\/10.1056\/NEJMoa2102953","journal-title":"N Engl J Med"},{"key":"5263_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.769335","volume":"8","author":"AM Cusumano","year":"2021","unstructured":"Cusumano AM, Tzanno-Martins C, Rosa-Diez GJ (2021) The glomerular filtration rate: from the diagnosis of kidney function to a public health tool. Front Med (Lausanne) 8:769335. https:\/\/doi.org\/10.3389\/fmed.2021.769335","journal-title":"Front Med (Lausanne)"},{"key":"5263_CR7","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMoa1214234","volume":"369","author":"MG Shlipak","year":"2013","unstructured":"Shlipak MG, Matsushita K, Arnlov J, Inker LA, Katz R, Polkinghorne KR et al (2013) Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 369:932\u2013943. https:\/\/doi.org\/10.1056\/NEJMoa1214234","journal-title":"N Engl J Med"},{"key":"5263_CR8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1053\/j.ajkd.2007.11.018","volume":"51","author":"LA Stevens","year":"2008","unstructured":"Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J et al (2008) Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD. Am J Kidney Dis 51:395\u2013406. https:\/\/doi.org\/10.1053\/j.ajkd.2007.11.018","journal-title":"Am J Kidney Dis"},{"key":"5263_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1681\/ASN.2005050545","volume":"17","author":"MG Shlipak","year":"2006","unstructured":"Shlipak MG, Wassel Fyr CL, Chertow GM, Harris TB, Kritchevsky SB, Tylavsky FA et al (2006) Cystatin C and mortality risk in the elderly: the Health, Aging, and Body Composition Study. J Am Soc Nephrol 17:254\u2013261. https:\/\/doi.org\/10.1681\/ASN.2005050545","journal-title":"J Am Soc Nephrol"},{"key":"5263_CR10","doi-asserted-by":"publisher","first-page":"1397160","DOI":"10.3389\/fmed.2024.1397160","volume":"11","author":"L Muglia","year":"2024","unstructured":"Muglia L, Di Dio M, Filicetti E, Greco GI, Volpentesta M, Beccacece A et al (2024) Biomarkers of chronic kidney disease in older individuals: navigating complexity in diagnosis. Front Med (Lausanne) 11:1397160. https:\/\/doi.org\/10.3389\/fmed.2024.1397160","journal-title":"Front Med (Lausanne)"},{"key":"5263_CR11","doi-asserted-by":"publisher","first-page":"1477500","DOI":"10.3389\/fmed.2024.1477500","volume":"11","author":"S Peruzzo","year":"2024","unstructured":"Peruzzo S, Ottaviani S, Tagliafico L, Muzyka M, Ponzano M, Marelli C et al (2024) Renal function assessment in older people: comparative analysis of estimation equation with serum creatinine. Front Med (Lausanne) 11:1477500. https:\/\/doi.org\/10.3389\/fmed.2024.1477500","journal-title":"Front Med (Lausanne)"},{"key":"5263_CR12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1053\/j.ajkd.2023.04.002","volume":"82","author":"JJ Carrero","year":"2023","unstructured":"Carrero JJ, Fu EL, Sang Y, Ballew SH, Evans M, Elinder CG et al (2023) Discordances between creatinine- and cystatin C-based estimated GFR and adverse clinical outcomes in routine clinical practice. Am J Kidney Dis 82:534\u2013542. https:\/\/doi.org\/10.1053\/j.ajkd.2023.04.002","journal-title":"Am J Kidney Dis"},{"issue":"21","key":"5263_CR13","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1001\/jama.2025.17578","volume":"334","author":"MM Estrella","year":"2025","unstructured":"Estrella MM, Ballew SH, Sang Y, Grams ME, Coresh J, Surapaneni A et al (2025) Discordance in creatinine- and cystatin C-based eGFR and clinical outcomes: a meta-analysis. JAMA 334(21):1915\u20131926. https:\/\/doi.org\/10.1001\/jama.2025.17578","journal-title":"JAMA"},{"key":"5263_CR14","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.2215\/CJN.0000000000000523","volume":"19","author":"N Katz-Agranov","year":"2024","unstructured":"Katz-Agranov N, Rieu-Werden ML, Thacker A, Lykken JM, Sise ME, Shah SJ (2024) Large discordance between creatinine-based and cystatin C-based eGFRs is associated with falls, hospitalizations, and death in older adults. Clin J Am Soc Nephrol 19:1275\u20131283. https:\/\/doi.org\/10.2215\/CJN.0000000000000523","journal-title":"Clin J Am Soc Nephrol"},{"key":"5263_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.810901","volume":"9","author":"JA Hwang","year":"2022","unstructured":"Hwang JA, Song Y, Shin J, Cho E, Ahn SY, Ko GJ et al (2022) Changes in mortality according to creatinine\/cystatin C ratio in chronic kidney disease and non-chronic kidney disease patients. Front Med (Lausanne) 9:810901. https:\/\/doi.org\/10.3389\/fmed.2022.810901","journal-title":"Front Med (Lausanne)"},{"key":"5263_CR16","doi-asserted-by":"publisher","first-page":"1477343","DOI":"10.3389\/fmed.2024.1477343","volume":"11","author":"X Wu","year":"2025","unstructured":"Wu X, Hu W, Xu J, Shen J, Lin L, Zhu J et al (2025) Difference between estimated glomerular filtration rate based on cystatin C versus creatinine and cardiovascular-kidney-metabolic health. Front Med (Lausanne) 11:1477343. https:\/\/doi.org\/10.3389\/fmed.2024.1477343","journal-title":"Front Med (Lausanne)"},{"key":"5263_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-024-05546-5","volume":"24","author":"S Wang","year":"2024","unstructured":"Wang S, Yang T, Bao Y, Zhou L, Jing P, Gu L et al (2024) Association of serum creatinine-cystatin C ratio with all-cause, cardiovascular and cancer mortality in US adults: a nationwide cohort study. BMC Geriatr 24:963. https:\/\/doi.org\/10.1186\/s12877-024-05546-5","journal-title":"BMC Geriatr"},{"issue":"3","key":"5263_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaf003","volume":"18","author":"Q Liu","year":"2025","unstructured":"Liu Q, Welsh P, Celis-Morales C, Ho FK, Lees JS, Mark PB (2025) Discordance between cystatin C-based and creatinine-based estimated glomerular filtration rate and health outcomes in adults: a systematic review and meta-analysis. Clin Kidney J 18(3):sfaf003. https:\/\/doi.org\/10.1093\/ckj\/sfaf003","journal-title":"Clin Kidney J"},{"key":"5263_CR19","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1093\/clinchem\/hvaf063","volume":"71","author":"Q Liu","year":"2025","unstructured":"Liu Q, Celis-Morales C, Lees JS, Sattar N, Ho FK, Pell JP et al (2025) Discordance between cystatin C-based and creatinine-based estimated glomerular filtration rate and mortality in the general population. Clin Chem 71:858\u2013869. https:\/\/doi.org\/10.1093\/clinchem\/hvaf063","journal-title":"Clin Chem"},{"key":"5263_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G (2014) Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol 43:61\u201368. https:\/\/doi.org\/10.1093\/ije\/dys203","journal-title":"Int J Epidemiol"},{"issue":"161","key":"5263_CR21","first-page":"1","volume":"2","author":"CL Johnson","year":"2013","unstructured":"Johnson CL, Paulose-Ram R, Ogden CL, Carroll MD, Kruszon-Moran D, Dohrmann SM et al (2013) National Health and Nutrition Examination Survey: analytic guidelines. Vital Health Stat 2(161):1\u201324","journal-title":"Vital Health Stat"},{"key":"5263_CR22","unstructured":"National Center for Health Statistics. The Linkage of National Center for Health Statistics Survey Data to the National Death Index - 2019 Linked Mortality File: Linkage Methodology and Analytic Considerations. Hyattsville: Centers for Disease Control and Prevention; 2021. Available from: https:\/\/www.cdc.gov\/nchs\/data\/datalinkage\/2019ndi-linkage-methods-and-analytic-considerations-508.pdf"},{"key":"5263_CR23","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology statement: guidelines for reporting observational studies. Lancet 370:1453\u20131457. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet"},{"key":"5263_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v009.i08","volume":"9","author":"T Lumley","year":"2004","unstructured":"Lumley T (2004) Analysis of complex survey samples. J Stat Softw 9:1\u201319. https:\/\/doi.org\/10.18637\/jss.v009.i08","journal-title":"J Stat Softw"},{"key":"5263_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR (1972) Regression models and life-tables. J R Stat Soc Series B 34:187\u2013220","journal-title":"J R Stat Soc Series B"},{"key":"5263_CR26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457\u2013481. https:\/\/doi.org\/10.1080\/01621459.1958.10501452","journal-title":"J Am Stat Assoc"},{"key":"5263_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-19425-7","volume-title":"Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis","author":"FE Harrell Jr.","year":"2015","unstructured":"Harrell FE Jr. (2015) Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis, 2nd ed. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-319-19425-7","edition":"2nd ed"},{"key":"5263_CR28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"PM Grambsch","year":"1994","unstructured":"Grambsch PM, Therneau TM (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:515\u2013526. https:\/\/doi.org\/10.1093\/biomet\/81.3.515","journal-title":"Biometrika"},{"key":"5263_CR29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496\u2013509. https:\/\/doi.org\/10.1080\/01621459.1999.10474144","journal-title":"J Am Stat Assoc"},{"key":"5263_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316696","volume-title":"Multiple imputation for nonresponse in surveys","author":"DB Rubin","year":"1987","unstructured":"Rubin DB (1987) Multiple imputation for nonresponse in surveys. John Wiley & Sons, New York. https:\/\/doi.org\/10.1002\/9780470316696"},{"key":"5263_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.32614\/RJ-2019-028","volume":"11","author":"M Quartagno","year":"2019","unstructured":"Quartagno M, Grund S, Carpenter J (2019) Jomo: a flexible package for two-level joint modelling multiple imputation. R J 11:205\u2013228. https:\/\/doi.org\/10.32614\/RJ-2019-028","journal-title":"R J"},{"key":"5263_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/sim.2929","volume":"27","author":"MJ Pencina","year":"2008","unstructured":"Pencina MJ, D\u2019Agostino RB Sr, D\u2019Agostino RB Jr, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157\u2013172. https:\/\/doi.org\/10.1002\/sim.2929","journal-title":"Stat Med"},{"key":"5263_CR33","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB (2006) Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 26:565\u2013574. https:\/\/doi.org\/10.1177\/0272989X06295361","journal-title":"Med Decis Making"},{"issue":"10","key":"5263_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14278","volume":"54","author":"T Stehle","year":"2024","unstructured":"Stehle T, Karger AB, Inker LA, Levey AS, Selvin E, Shlipak MG (2024) Which is the best glomerular filtration marker: creatinine, cystatin C or both? Eur J Clin Invest 54(10):e14278. https:\/\/doi.org\/10.1111\/eci.14278","journal-title":"Eur J Clin Invest"},{"key":"5263_CR35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.7326\/0003-4819-145-4-200608150-00003","volume":"145","author":"MG Shlipak","year":"2006","unstructured":"Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C et al (2006) Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 145:237\u2013246. https:\/\/doi.org\/10.7326\/0003-4819-145-4-200608150-00003","journal-title":"Ann Intern Med"},{"key":"5263_CR36","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"Chronic Kidney Disease Prognosis Consortium","year":"2010","unstructured":"Chronic Kidney Disease Prognosis Consortium (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375:2073\u20132081. https:\/\/doi.org\/10.1016\/S0140-6736(10)60674-5","journal-title":"Lancet"},{"key":"5263_CR37","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","volume":"3","author":"K Matsushita","year":"2015","unstructured":"Matsushita K, Coresh J, Sang Y, Chalmers J, Fox C, Guallar E et al (2015) Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol 3:514\u2013525. https:\/\/doi.org\/10.1016\/S2213-8587(15)00040-6","journal-title":"Lancet Diabetes Endocrinol"},{"key":"5263_CR38","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jama.2023.17002","volume":"330","author":"ME Grams","year":"2023","unstructured":"Writing Group for the CKD Prognosis Consortium, Grams ME, Coresh J, Matsushita K et al (2023) Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis. JAMA 330:1266\u20131277. https:\/\/doi.org\/10.1001\/jama.2023.17002","journal-title":"JAMA"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05263-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05263-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05263-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:33:35Z","timestamp":1783352015000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05263-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":38,"alternative-id":["5263"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05263-5","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"5 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This study used publicly available, de-identified data from CHARLS and NHANES. CHARLS was approved by the Biomedical Ethics Review Committee of Peking University, and all participants provided written informed consent. NHANES protocols were approved by the National Center for Health Statistics Research Ethics Review Board, and all participants provided written informed consent. The original CHARLS and NHANES protocols were conducted in accordance with the Declaration of Helsinki. Because the present study was a secondary analysis of de-identified public-use data, no additional institutional review board approval was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}